If the initial request is denied, your clinician can also lead the appeals process
This is a direct result of the drug's intended mechanismslowing stomach emptying and reducing appetiterather than a sign of toxicity or organ damage
For example, a patient with favorable GLP1R and GIPR variants might explore tirzepatide, while someone with atypical GLP1R variants might benefit from starting with a lower-dose or microdose protocol
In summary, both menopause and perimenopause bring significant changes to the body, particularly concerning weight
It provides powerful control over the hypothalamic-pituitary-gonadal axis, making it valuable for post-cycle therapy, fertility protocols, and hormonal reset strategies
The report, which reviewed more than 440 new drug and supplemental submissions made to Health Canada in [] Canadian benefits plan sponsors are anticipating an average medical trend rate of 8.3 per cent in 2026, up from 7.4 per cent in 2025, according to a new report by Aon